Immunovant Ownership | Who Owns Immunovant?

Overview Forecast RevenueFinancials Chart Transcripts

Immunovant Ownership Summary

Immunovant is owned by 54.48% institutional investors, 56.02% insiders. Fmr is the largest institutional shareholder, holding 7.95% of IMVT shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 3.36% of its assets in Immunovant shares.

IMVT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Immunovant	54.48%	56.02%	-10.50%
Sector	Healthcare Stocks	50.51%	12.37%	37.12%
Industry	Biotech Stocks	48.95%	12.07%	38.98%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Fmr	16.19M	7.95%	$623.66M
Deep track capital, lp	9.34M	4.59%	$359.91M
Vanguard group	7.78M	4.48%	$197.75M
Blackrock	4.92M	3.56%	$129.79M
Blackrock funding, inc. /de	7.18M	3.53%	$276.68M
Farallon capital management	5.80M	2.85%	$223.67M
Baker bros. advisors lp	5.44M	2.67%	$209.42M
State street	4.62M	2.27%	$177.89M
Morgan stanley	4.53M	2.23%	$174.73M
Tcg crossover management	4.46M	2.19%	$171.77M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Alpine global management	1.38M	8.61%	$52.98M
Deep track capital, lp	9.34M	5.24%	$359.91M
Superstring capital management lp	208.37K	5.07%	$8.03M
Tcg crossover management	4.46M	4.13%	$171.77M
Adar1 capital management	2.33M	4.11%	$89.80M
Silverarc capital management	619.10K	2.48%	$23.85M
Highvista strategies	277.87K	2.44%	$10.71M
Two seas capital lp	3.15M	2.40%	$121.31M
Stempoint capital lp	276.53K	1.84%	$10.65M
Tfg asset management gp	255.93K	1.55%	$9.86M

Top Buyers

Holder	Shares	% Assets	Change
Farallon capital management	5.80M	1.03%	4.26M
Price t rowe associates inc /md/	1.83M	0.01%	1.49M
D. e. shaw	1.24M	0.02%	1.24M
Vanguard group	7.78M	0.00%	952.50K
Sixth street partners management company	680.59K	0.00%	680.59K

Top Sellers

Holder	Shares	% Assets	Change
Deep track capital, lp	9.34M	5.24%	-2.19M
Point72 asset management	-	-	-2.00M
Armistice capital	1.74M	0.82%	-1.83M
T. rowe price investment management	2.22M	0.06%	-1.39M
Paradigm biocapital advisors lp	-	-	-1.36M

New Positions

Holder	Shares	% Assets	Change	Value
D. e. shaw	1.24M	0.02%	1.24M	$47.80M
Sixth street partners management company	680.59K	0.00%	680.59K	$26.22M
Balyasny asset management	197.57K	0.00%	197.57K	$3.16M
Man group	140.12K	0.01%	140.12K	$5.40M
Eam investors	127.27K	0.44%	127.27K	$4.90M

Sold Out

Holder	Change
Dunhill financial	-1.00
Reuter james wealth management	-1.00
Physician wealth advisors	-1.00
Capital performance advisors llp	-3.00
Twin peaks wealth advisors	-3.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	236	4.42%	110,973,566	0.34%	54	1.48%	112	-19.42%	81	97.56%
Mar 31, 2026	139	-33.17%	27,270,250	-74.89%	15	0.38%	89	-22.61%	21	-61.11%
Dec 31, 2025	165	-16.24%	62,414,346	-34.42%	35	1.16%	93	-4.12%	40	-23.08%
Sep 30, 2025	191	5.52%	94,495,463	-1.81%	55	1.74%	93	-6.06%	51	2.00%
Jun 30, 2025	178	-15.64%	96,201,301	3.59%	56	1.41%	96	-25.58%	50	19.05%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl S	6.94M	3.36%	-
Fidelity Growth Compy Commingled Pl O	4.45M	3.04%	196.00K
Fidelity Growth Company Fund	5.09M	2.48%	-6.29K
Vanguard Total Stock Mkt Idx Inv	2.60M	1.27%	-14.64K
Vanguard Morn Total Stk Mkt Idx Investor	2.60M	1.27%	-14.64K
Vanguard MStar Total Stk Mkt Idx Invest	2.61M	1.27%	11.52K
Vanguard US Total Market Shares ETF	2.12M	1.25%	2.26K
State Street® SPDR® S&P® Biotech ETF	2.53M	1.23%	5.81K
iShares Russell 2000 ETF	2.16M	1.04%	-38.30K
Vanguard Small Cap Index	1.89M	0.92%	4.79K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 20, 2026	Gloria Melanie	Chief Operating Officer	Sell	$134.95K
Jul 24, 2026	Pande Atul	-	Sell	$59.70K
Jul 23, 2026	Girao Tiago	Chief Financial Officer	Sell	$263.01K
Jul 23, 2026	Stout Jay S	Chief Technology Officer	Sell	$110.54K
Jul 08, 2026	Gloria Melanie	Chief Operating Officer	Sell	$76.29K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	13
2026 Q2	-	25
2026 Q1	-	7
2025 Q4	1	12
2025 Q3	-	4

IMVT Ownership FAQ

Who Owns Immunovant?

Immunovant shareholders are primarily institutional investors at 54.48%, followed by 56.02% insiders and -10.50% retail investors. The average institutional ownership in Immunovant's industry, Biotech Stocks , is 48.95%, which Immunovant exceeds.

Who owns the most shares of Immunovant?

Immunovant’s largest shareholders are Fmr (16.19M shares, 7.95%), Deep track capital, lp (9.34M shares, 4.59%), and Vanguard group (7.78M shares, 4.48%). Together, they hold 17.01% of Immunovant’s total shares outstanding.

Does Blackrock own Immunovant?

Yes, BlackRock owns 3.56% of Immunovant, totaling 4.92M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 129.79M$. In the last quarter, BlackRock increased its holdings by 439.33K shares, a 9.81% change.

Who is Immunovant’s biggest shareholder by percentage of total assets invested?

Alpine global management is Immunovant’s biggest shareholder by percentage of total assets invested, with 8.61% of its assets in 1.38M Immunovant shares, valued at 52.98M$.

Who is the top mutual fund holder of Immunovant shares?

Fidelity Growth Compy Commingled Pl S is the top mutual fund holder of Immunovant shares, with 3.36% of its total shares outstanding invested in 6.94M Immunovant shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools